Table: begin end state 1 12 cytoplasmic 13 35 transmembrane 36 41 non-cytoplasmic 42 60 transmembrane 61 80 cytoplasmic 81 102 transmembrane 103 121 non-cytoplasmic 122 140 transmembrane 141 150 cytoplasmic 151 172 transmembrane 173 191 non-cytoplasmic 192 216 transmembrane 217 236 cytoplasmic 237 256 transmembrane 257 276 non-cytoplasmic 277 297 transmembrane 298 329 cytoplasmic 330 349 transmembrane 350 354 non-cytoplasmic 355 379 transmembrane 380 392 cytoplasmic 393 414 transmembrane 415 419 non-cytoplasmic 420 439 transmembrane 440 453 cytoplasmic
Input: >N515DRAFT_3653 FitnessBrowser__Dyella79:N515DRAFT_3653 MTQHLQRRLTPRHITFMALGMAIGAGLFLGSANAINLAGPSVLFAYLFGGAMIFIIMRAL GEMAVHDPVAGSFSTYAHRYLGPFAGYLTGWNYWILMVGVGMAESTAVGIYMRQWFPELP QWIWVFGSVAMIGGLNLMAVKVYGEMEFWFTLIKVVTVVLMILGGAGMIWLGWGNGGQPV GLANLWSHGGWFPHGFTGMVLALPVVVFAFGGIETIGMAAGEAAQPERTIPRAVNSVLWR ILIFYVGALFVIMAIYPWDQLGTQGSPFVTTFGKLGIPQAAGLINFVVITAALSGFNSTT FSGSRMLYSLSTKAQAPAFLGQVSEHGVPVRAVLVTLACLVFGVVLNYLLPERIFAMMMS ILAFNTVWTWMMVLIAHYSFRRRHGATAFPLRAWPLTSVVCLLFLAFVLFMLGYSADTRV ALYVGAGWVVLLSLAYRLLGIGARMRALEPRAI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server